NPPB and atrial fibrillation: In the present study, we proved for the first time that NT‐proBNP can provide additional prognostic information beyond the CHA2DS2‐VASc score for all‐cause death, cardiac death, and MACCE, indicating NT‐proBNP as a value‐added biomarker to risk stratification in patients with concomitant ACS and AF.